Skip to main content
Fig. 1 | Harm Reduction Journal

Fig. 1

From: Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Fig. 1

a Estimated composition of medical cannabis; b main method of administering; c change in main condition following treatment with medical cannabis (PGIC); d consumer perception of ease of access to medical cannabis treatment. Cells without percentages were all ≤ 6%. In panels a and b, outcomes were treated as unordered categorical. In these panels, portions of graph of the same shade but with different letters are significantly different proportions. In panels c and d, outcome was treated as ordinal and different letters indicate significantly different odds of indicating a higher category vs a lower category

Back to article page